Structural Biology & Molecular Modeling Techniques Market Research Report by Tools (Databases, SaaS & standalone modeling, and Visualization & analysis), by Application (Drug Development and Drug Discovery), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2026 – Cumulative Impact of COVID-19
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "Structural Biology & Molecular Modeling Techniques Market Research Report by Tools, by Application, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19" – https://www.reportlinker.com/p06178503/?utm_source=GNW
The Global Structural Biology & Molecular Modeling Techniques Market size was estimated at USD 5,713.68 million in 2020 and expected to reach USD 6,731.28 million in 2021, at a CAGR 18.14% to reach USD 15,541.15 million by 2026.
The report provides market sizing and forecast across five major currencies – USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Structural Biology & Molecular Modeling Techniques to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Tools , the market was studied across Databases, SaaS & standalone modeling, and Visualization & analysis. The SaaS & standalone modeling is further studied across Ab Initio, Homology modeling, Hybrid, Molecular dynamics, and Threading.
Based on Application, the market was studied across Drug Development and Drug Discovery.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Structural Biology & Molecular Modeling Techniques Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Structural Biology & Molecular Modeling Techniques Market, including Acellera Ltd., Adjuvance Technologies, Inc., Agenus Inc., Agile Molecule, Agilent Technologies, Inc., Avanti Polar Lipid, BioInformatics, LLC, Biomax Informatics AG, Brenntag SE, Bruker Daltonics Inc., Chemical Computing Group, CLC bio, Dassault Systèmes SE, Illumina, Inc., InvivozGen, Novartis International AG, Novavax, Inc., SPI Pharma, and Thermo Fisher Scientific, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Structural Biology & Molecular Modeling Techniques Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Structural Biology & Molecular Modeling Techniques Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Structural Biology & Molecular Modeling Techniques Market?
4. What is the competitive strategic window for opportunities in the Global Structural Biology & Molecular Modeling Techniques Market?
5. What are the technology trends and regulatory frameworks in the Global Structural Biology & Molecular Modeling Techniques Market?
6. What is the market share of the leading vendors in the Global Structural Biology & Molecular Modeling Techniques Market?
7. What modes and strategic moves are considered suitable for entering the Global Structural Biology & Molecular Modeling Techniques Market?
Read the full report: https://www.reportlinker.com/p06178503/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
Wood believes we're still in a strong bull market. Take advantage.
EV stocks are being dumped as a group today, even with these three names reporting good news recently.
More than 90 large-cap stocks are down at least 20% from their 2021 highs, but analysts love many of them, including JD.com, PayPal and Disney.
Buffett is taking profits off the table. It might be time to do the opposite.
Losing money in the S&P 500 is never fun. But it stings all the more when everyone else is making tons on their stocks.
A cosmetics and skin care products company founded by married Taiwanese actors Zhang Ting and Lin Ruiyang has had assets worth 600 million yuan (US$94 million) frozen due to an investigation by China's market regulator over an alleged pyramid scheme. The market regulator in Shijiazhuang, the capital of northern China's Hebei province, said it had received several reports about a suspected pyramid scheme involving Shanghai Dowell Trading, according to a letter widely circulated on Chinese social
Get aboard the Tesla stock train, argues Dan Ives at Wedbush.
Biogen, which owns nearly half of a Samsung unit, shares surged Wednesday. A South Korean newspaper reported that Samsung wants to buy Biogen for as much as $42 billion.
Yahoo Finance Live's Jared Blikre examines the latest market action, in addition to reporting on Biogen undergoing acquisition negotiations by Samsung
These stocks are trading near their 52-week lows but have tremendous long-term growth opportunities.
Nvidia (NASDAQ: NVDA) stock dropped in Wednesday trading and is down 2% as of 11 a.m. ET, and bad news out of China may be the reason. This morning, Samsung announced that "due to the ongoing COVID-19 situation, we have decided to temporarily adjust operations at our manufacturing facilities in Xian, China." What does a Samsung plant in China have to do with a sliding stock price for Nvidia?
The American Idol alum defended her husband from backlash on Instagram, writing, "Stop being so offended by what people post who have zero impact on your life and move on"
(Bloomberg) — SenseTime Group Inc. co-founder Tang Xiao’ou has become one of the world’s richest people, after the Chinese AI champion blew past concerns about American sanctions to surge as much as 23% on its Hong Kong debut.Most Read from BloombergGhislaine Maxwell Found Guilty in Win for Epstein VictimsMercedes Swept Up in China Internet Furor Over Models’ EyesApple Aims to Prevent Defections to Meta With Rare $180,000 Bonuses for Top TalentThe Senator Who Could Rescue Biden’s AgendaCovid Wi
The stock has already managed to settle below the $115 level and is moving towards yearly lows at $108.70.
(Bloomberg) — Didi Global Inc. disclosed a $4.7 billion loss after revenues shrank in the September quarter, revealing the rising cost of a series of regulatory actions that will force China’s ride-sharing leader to shift its listing to Hong Kong next year.Most Read from BloombergGhislaine Maxwell Found Guilty in Win for Epstein VictimsMercedes Swept Up in China Internet Furor Over Models’ EyesApple Aims to Prevent Defections to Meta With Rare $180,000 Bonuses for Top TalentThe Senator Who Coul
Time's almost up on ultra-low rates, so don't be caught off guard.
The rally in Victoria's Secret may just be getting started, contends JP Morgan retail analyst Matt Boss.
If you want to leave some stocks to your heirs, then you'll want to find companies like these that are poised to thrive for decades to come.
Investors are buying options against falling prices ahead of a major expiry.
The need of a robust charging infrastructure to support the growth of electric vehicles (EVs) is undisputed. What isn't as clear is which players will be instrumental in developing this infrastructure and, more importantly, whether can they do this profitably. Let's discuss which of the two top EV charging stocks, ChargePoint (NYSE: CHPT) and Blink Charging (NASDAQ: BLNK), is a better buy right now.